Crossmark

Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation

Crossref DOI link: https://doi.org/10.1007/s13246-021-01022-1

Published Online: 2021-06-01

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ji, Xuefu

Zhang, Jiayi

Shi, Wei

He, Dong

Bao, Jie

Wei, Xuedong

Huang, Yuhua

Liu, Yangchuan

Chen, Jyh-Cheng

Gao, Xin

Tang, Yuguo

Xia, Wei https://orcid.org/0000-0003-3368-4050
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (61801474)

National Natural Science Foundation of China (61801475)

CAS-VPST Slik Road Science Fund 2018 (GJHZ1857)

Science and Technology Plan Project of Tianjin (19YDYGHZ00030)

Suzhou science and technology plan project (SYG201908)

Suzhou science and technology plan project (SS201863)
License Information

Text and Data Mining valid from 2021-06-01

Version of Record valid from 2021-06-01
More Information

Article History

Received: 15 October 2020

Accepted: 26 May 2021

First Online: 1 June 2021

Declarations

:

: The authors declared that they have no conflict of interest.

: Institutional Review Board approval was obtained in concordance with the standards of the First Affiliated Hospital of Soochow University Ethics Committee (2020; approval no. 064). All procedures performed in this study, which involved human participants, were in accordance with the ethical standards of the institutional and/or nation research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Approved by the ethics committee of the First Affiliated Hospital of Soochow University Ethics Committee, this retrospective analysis was involving MRI of patients in and informed consent was waived for all patients.

Document is current

Any future updates will be listed below